167 related articles for article (PubMed ID: 31150157)
1. Low-Dose Methotrexate and Mucocutaneous Adverse Events: Results of a Systematic Literature Review and Meta-Analysis of Randomized Controlled Trials.
Lalani R; Lyu H; Vanni K; Solomon DH
Arthritis Care Res (Hoboken); 2020 Aug; 72(8):1140-1146. PubMed ID: 31150157
[TBL] [Abstract][Full Text] [Related]
2. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
[TBL] [Abstract][Full Text] [Related]
3. The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): a masked and controlled study.
Ince A; Yazici Y; Hamuryudan V; Yazici H
Clin Rheumatol; 1996 Sep; 15(5):491-4. PubMed ID: 8894364
[TBL] [Abstract][Full Text] [Related]
4. Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials.
Vanni KMM; Lyu H; Solomon DH
Rheumatology (Oxford); 2020 Apr; 59(4):709-717. PubMed ID: 31504937
[TBL] [Abstract][Full Text] [Related]
5. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Ghogomu ET; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
[TBL] [Abstract][Full Text] [Related]
6. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
[TBL] [Abstract][Full Text] [Related]
7. Oral effects of low-dose methotrexate treatment.
Kalantzis A; Marshman Z; Falconer DT; Morgan PR; Odell EW
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):52-62. PubMed ID: 15953917
[TBL] [Abstract][Full Text] [Related]
8. A Pilot Randomized Controlled Double-Blind Trial of High- Versus Low-Dose Weekly Folic Acid in People With Rheumatoid Arthritis Receiving Methotrexate.
Stamp LK; OʼDonnell JL; Frampton C; Drake J; Zhang M; Barclay M; Chapman PT
J Clin Rheumatol; 2019 Oct; 25(7):284-287. PubMed ID: 30001258
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.
Mori S; Hidaka M; Kawakita T; Hidaka T; Tsuda H; Yoshitama T; Migita K; Ueki Y
PLoS One; 2016; 11(4):e0154744. PubMed ID: 27128679
[TBL] [Abstract][Full Text] [Related]
10. [Reducing toxicity of methotrexate with folic acid].
Harten P
Z Rheumatol; 2005 Jun; 64(5):353-8. PubMed ID: 15965822
[TBL] [Abstract][Full Text] [Related]
11. [Ulcerative stomatitis as clinical clue to inadvertent methotrexate overdose].
Bauer J; Fartasch M; Schuler G; Schell H
Hautarzt; 1999 Sep; 50(9):670-3. PubMed ID: 10501685
[TBL] [Abstract][Full Text] [Related]
12. Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: A Systematic Review.
Liu L; Liu S; Wang C; Guan W; Zhang Y; Hu W; Zhang L; He Y; Lu J; Li T; Liu X; Xuan Y; Wang P
J Clin Rheumatol; 2019 Aug; 25(5):197-202. PubMed ID: 29975207
[TBL] [Abstract][Full Text] [Related]
13. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
[TBL] [Abstract][Full Text] [Related]
14. Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis.
Lasheen S; Shohdy KS; Kassem L; Abdel-Rahman O
Expert Rev Anticancer Ther; 2017 Sep; 17(9):851-856. PubMed ID: 28699811
[TBL] [Abstract][Full Text] [Related]
15. A 2018 Approach to Combating Methotrexate Toxicity Folic Acid and Beyond.
Labadie JG; Hashim R; Raheel S; Awad L; Jain M
Bull Hosp Jt Dis (2013); 2018 Sep; 76(3):151-155. PubMed ID: 31513516
[TBL] [Abstract][Full Text] [Related]
16. Oral mucositis in patients receiving low-dose methotrexate therapy for rheumatoid arthritis: report of 2 cases and literature review.
Troeltzsch M; von Blohn G; Kriegelstein S; Woodlock T; Gassling V; Berndt R; Troeltzsch M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 May; 115(5):e28-33. PubMed ID: 23601229
[TBL] [Abstract][Full Text] [Related]
17. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
[TBL] [Abstract][Full Text] [Related]
19. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis.
Hartman M; van Ede A; Severens JL; Laan RF; van de Putte L; van der Wilt GJ
J Rheumatol; 2004 May; 31(5):902-8. PubMed ID: 15124248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
